Drug profile · INN
bisoprolol fumarate
BISOPROLOL FUMARATE
bisoprolol fumarate (BISOPROLOL FUMARATE) is a beta-1 adrenergic receptor antagonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Drug details — bisoprolol fumarate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 2
- Data quality
- 0.89
Quick answer
bisoprolol fumarate (BISOPROLOL FUMARATE) is a beta-1 adrenergic receptor antagonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Beta-1 adrenergic receptor antagonist
Primary target: Beta-1 adrenergic receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is bisoprolol fumarate?
bisoprolol fumarate (BISOPROLOL FUMARATE) is a beta-1 adrenergic receptor antagonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for bisoprolol fumarate?
BISOPROLOL FUMARATE is a marketed brand name for bisoprolol fumarate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of bisoprolol fumarate?
bisoprolol fumarate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.